135 related articles for article (PubMed ID: 1954991)
21. Hyperreactive cellular immunity in multiple myeloma.
Reibnegger G; Wachter H; Krainer M; Ludwig H; Herold M; Huber H
Blood; 1992 Apr; 79(8):2174-6. PubMed ID: 1562745
[No Abstract] [Full Text] [Related]
22. [Serum beta 2-microglobulin in multiple myeloma. I. Relation to selected indicators, clinical stage and disease prognosis].
Scudla V; Budíková M; Fischerová E; Raska I; Vavrdová V
Vnitr Lek; 1991 Apr; 37(4):342-51. PubMed ID: 2053304
[TBL] [Abstract][Full Text] [Related]
23. Non-invasive markers of bone turnover and plasma cytokines differ in osteoporotic patients with multiple myeloma and monoclonal gammopathies of undetermined significance.
Diamond T; Levy S; Smith A; Day P; Manoharan A
Intern Med J; 2001 Jul; 31(5):272-8. PubMed ID: 11512598
[TBL] [Abstract][Full Text] [Related]
24. [Value of the assay of urinary neopterin in multiple myeloma. Preliminary study].
Thomas P; Mura P; Tallineau C; Bounaud MP; Reiss D; Bontoux D
Rev Rhum Mal Osteoartic; 1985 Jun; 52(6):381-3. PubMed ID: 3901228
[TBL] [Abstract][Full Text] [Related]
25. Serum thymidine kinase and beta-2 microglobulin in monoclonal gammopathies.
Ucci G; Riccardi A; Luoni R; Spriano P; Merlini G; Danova M; Cassano E; Molinari E; Ascari E
Tumori; 1987 Oct; 73(5):445-9. PubMed ID: 3318049
[TBL] [Abstract][Full Text] [Related]
26. Serum beta-2-microglobulin in the differential diagnosis of monoclonal gammopathies.
Elias J; Dauth J; Senekal JC; van der Walt P; Joubert HF; Kühn F; Greenacre M
S Afr Med J; 1991 Jun; 79(11):650-3. PubMed ID: 2047946
[TBL] [Abstract][Full Text] [Related]
27. Serum bone sialoprotein as a marker of tumour burden and neoplastic bone involvement and as a prognostic factor in multiple myeloma.
Woitge HW; Pecherstorfer M; Horn E; Keck AV; Diel IJ; Bayer P; Ludwig H; Ziegler R; Seibel MJ
Br J Cancer; 2001 Feb; 84(3):344-51. PubMed ID: 11161399
[TBL] [Abstract][Full Text] [Related]
28. Multiple myeloma: increased circulating lymphocytes carrying plasma cell-associated antigens as an indicator of poor survival.
Omedé P; Boccadoro M; Gallone G; Frieri R; Battaglio S; Redoglia V; Pileri A
Blood; 1990 Oct; 76(7):1375-9. PubMed ID: 2119828
[TBL] [Abstract][Full Text] [Related]
29. Changes in serum neopterin and serum beta 2-microglobulin in subjects with lung infections.
Carstens J; Andersen PL
Eur Respir J; 1994 Jul; 7(7):1233-8. PubMed ID: 7925900
[TBL] [Abstract][Full Text] [Related]
30. Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.
Rajkumar SV; Mesa RA; Fonseca R; Schroeder G; Plevak MF; Dispenzieri A; Lacy MQ; Lust JA; Witzig TE; Gertz MA; Kyle RA; Russell SJ; Greipp PR
Clin Cancer Res; 2002 Jul; 8(7):2210-6. PubMed ID: 12114422
[TBL] [Abstract][Full Text] [Related]
31. Serum neural cell adhesion molecule differentiates multiple myeloma from paraproteinemias due to other causes.
Ong F; Kaiser U; Seelen PJ; Hermans J; Wijermans PW; de Kieviet W; Jaques G; Kluin-Nelemans JC
Blood; 1996 Jan; 87(2):712-6. PubMed ID: 8555495
[TBL] [Abstract][Full Text] [Related]
32. [Lymphocyte subpopulations, neopterin, and beta-2-microglobulin: relationship with clinical stage, risk of progression to AIDS and presence of active infection in HIV infection].
Antón F; Labarga P; Pinilla J; Soto MJ; Leoz A; del Cura J; Borque L; Milazzo A
Enferm Infecc Microbiol Clin; 1993; 11(7):373-7. PubMed ID: 8104488
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-6 in multiple myeloma: correlation with disease activity and Ki-67 proliferation index.
Thaler J; Fechner F; Herold M; Huber H
Leuk Lymphoma; 1994 Jan; 12(3-4):265-71. PubMed ID: 8167557
[TBL] [Abstract][Full Text] [Related]
34. Intrathecal production of neopterin and beta 2 microglobulin in tick-borne encephalitis (TBE) compared to meningoencephalitis of other etiology.
Günther G; Haglund M; Lindquist L; Sköldenberg B; Forsgren M
Scand J Infect Dis; 1996; 28(2):131-8. PubMed ID: 8792478
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of urinary neopterin levels in patients with hepatocellular carcinoma.
Kawasaki H; Watanabe H; Yamada S; Watanabe K; Suyama A
Tohoku J Exp Med; 1988 Aug; 155(4):311-8. PubMed ID: 2852855
[TBL] [Abstract][Full Text] [Related]
36. Natural killer cell frequency and serum cytokine levels in monoclonal gammopathies: correlation of bone marrow granular lymphocytes to prognosis.
Sawanobori M; Suzuki K; Nakagawa Y; Inoue Y; Utsuyama M; Hirokawa K
Acta Haematol; 1997; 98(3):150-4. PubMed ID: 9352746
[TBL] [Abstract][Full Text] [Related]
37. 2',5'-oligoadenylate synthetase, neopterin and beta 2-microglobulin in asymptomatic HIV-infected individuals.
Witt PL; Spear GT; Lindstrom MJ; Kessler HA; Borden EC; Phair J; Landay AL
AIDS; 1991 Mar; 5(3):289-93. PubMed ID: 2059368
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-2, soluble interleukin-2-receptor, neopterin, L-tryptophan and beta 2-microglobulin levels in CSF and serum of patients with relapsing-remitting or chronic-progressive multiple sclerosis.
Ott M; Demisch L; Engelhardt W; Fischer PA
J Neurol; 1993 Dec; 241(2):108-14. PubMed ID: 8138825
[TBL] [Abstract][Full Text] [Related]
39. [The clinical importance of the dynamic determination of the serum neopterin level in patients with dilated cardiomyopathy].
Samsonov MIu; Nasonov EL; Masenko VP; Naumov VG; Mareev VIu; Belenkov IuN
Ter Arkh; 1991; 63(9):133-6. PubMed ID: 1759206
[TBL] [Abstract][Full Text] [Related]
40. [Serum neopterin in hepatitis B].
Samsonov MIu; Golban TD; Nasonov EL; Masenko VP
Klin Med (Mosk); 1992; 70(3-4):40-2. PubMed ID: 1507845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
